Tuesday, March, 17 2026 - The National Agency for Food and Drug Administration and Control, NAFDAC, has warned the public about the recall of all batches of MR.7 Super 700000 capsules following safety concerns linked to undisclosed pharmaceutical ingredients.
The agency disclosed this on Monday in a public notice
published on its website.
According to NAFDAC, the recall was initiated by the
manufacturer, StuffbyNainax LLC, after the U.S. Food and Drug Administration
(FDA) tested the product and discovered it contains undeclared sildenafil and
tadalafil.
These substances are commonly used in medications approved
for treating Erectile Dysfunction.
NAFDAC explained that both ingredients belong to a group of
medicines known as phosphodiesterase (PDE-5) inhibitors. Because the substances
were not listed on the product label, the capsules are regarded as unapproved
drugs whose safety and effectiveness have not been verified.
The product, which is promoted online as a dietary
supplement for male enhancement, should not be sold as a supplement if it
contains sildenafil or tadalafil, the agency stated.
The advisory identified the product as MR.7 Super 700000
capsules, manufactured by StuffbyNainax LLC and marketed as a male enhancement
supplement. The recall applies to all batches currently available.
NAFDAC advised anyone in possession of the capsules to stop
using or selling them and return them to the nearest NAFDAC office.
The agency also urged healthcare professionals and consumers
to report suspected counterfeit or substandard medicines and any adverse
reactions through its official reporting channels.
NAFDAC warned that consuming products containing undeclared
sildenafil or tadalafil could pose serious health risks.
The agency explained that these substances can react with
nitrates found in prescription medicines used to treat heart conditions,
including Nitroglycerin. Such interactions may cause a sharp drop in blood
pressure, which can be life-threatening.
People living with diabetes, high blood pressure, high
cholesterol, or heart disease who often take nitrate-based drugs may be
particularly vulnerable. Adult men using nitrates for cardiac conditions face
the highest risk if they take the capsules.
The recall follows recent alerts by NAFDAC about the
circulation of unsafe and falsified medicines in Nigeria.
The agency recently warned health workers and the public
about counterfeit Avastin 400 mg vials circulating in the country.
The medicine, known as Avastin (Bevacizumab), is used to
treat recurrent Glioblastoma in adults by blocking blood vessels that feed
tumours.
According to NAFDAC, the suspected fake product was first
reported by Roche after an oncologist at a local hospital questioned the
authenticity of some Avastin vials labelled 400 mg/16 ml.
The agency reaffirmed its commitment to protecting public
health through continued monitoring of the safety, quality and effectiveness of
medicines and other regulated products in Nigeria.
0 Comments